ProbstYCGuanVXKentK. Dietary phytochemical intake from foods and health outcomes: A systematic review protocol and preliminary scoping. BMJ Open2017; 7: e013337–e013337.
2.
JohnstonTPKorolenkoTAPirroM, et al.Preventing cardiovascular heart disease: Promising nutraceutical and non-nutraceutical treatments for cholesterol management. Pharmacol Res2017; 120: 219–225.
3.
MangelsDRMohler3rdER. Catechins as potential mediators of cardiovascular health. Arterioscler Thromb Vasc Biol2017; 37: 757–763.
4.
BianconiVMannarinoMRSahebkarA, et al.Cholesterol-lowering nutraceuticals affecting vascular function and cardiovascular disease risk. Curr Cardiol Rep2018; 20: 53–53.
5.
ZhangCQinYYWeiX, et al.Tea consumption and risk of cardiovascular outcomes and total mortality: A systematic review and meta-analysis of prospective observational studies. Eur J Epidemiol2015; 30: 103–113.
6.
AbeSKSaitoESawadaN, et al.Green tea consumption and mortality in Japanese men and women: A pooled analysis of eight population-based cohort studies in Japan. Eur J Epidemiol2019; 34: 917–926.
7.
ZhaoLGLiHLSunJW, et al.Green tea consumption and cause-specific mortality: Results from two prospective cohort studies in China. J Epidemiol2017; 27: 36–41.
8.
YanYSuiXYaoB, et al.Is there a dose-response relationship between tea consumption and all-cause, CVD, and cancer mortality?J Am Coll Nutr2017; 36: 281–286.
9.
TangJZhengJSFangL, et al.Tea consumption and mortality of all cancers, CVD and all causes: A meta-analysis of eighteen prospective cohort studies. Br J Nutr2015; 114: 673–683.
10.
de Koning GansJMUiterwaalCSvan der SchouwYT, et al.Tea and coffee consumption and cardiovascular morbidity and mortality. Arterioscler Thromb Vasc Biol2010; 30: 1665–1671.
11.
GardenerHRundekTWrightCB, et al.Coffee and tea consumption are inversely associated with mortality in a multiethnic urban population. J Nutr2013; 143: 1299–1308.
12.
Wang X, et al. Tea consumption and the risk of atherosclerotic cardiovascular disease and all-cause mortality: The China-PAR project. Eur J Prev Cardiol. 2020; 27: 1956–1963.
13.
KuriyamaSShimazuTOhmoriK, et al.Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA2006; 296: 1255–1265.
14.
YarmolinskyJGonGEdwardsP. Effect of tea on blood pressure for secondary prevention of cardiovascular disease: A systematic review and meta-analysis of randomized controlled trials. Nutr Rev2015; 73: 236–246.
15.
IkedaAIsoHYamagishiK, et al.Blood pressure and the risk of stroke, cardiovascular disease, and all-cause mortality among Japanese: the JPHC Study. Am J Hypertens2009; 22: 273–280.
16.
ZhouMWangHZengX, et al.Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet2019; 394: 1145–1158.
17.
KhanNMukhtarH. Tea polyphenols for health promotion. Life Sci2007; 81: 519–533.
